Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Veteran's claims for increased ratings for diabetes mellitus and bilateral diabetic retinopathy were denied. The Board found that the evidence did not support a higher rating based on current symptoms.

The deciding factor: The Veteran's diabetes mellitus was currently rated as 20% disabling, which is already in line with his reported need for insulin and restricted diet. His bilateral diabetic retinopathy was rated at 10%, reflecting no significant visual impairment or complications.

Claimed conditions
diabetes mellitus type II, bilateral diabetic retinopathy
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
10%
Decision date
January 14, 2016
Citation
1601682

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1601682.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.